tiprankstipranks
Trending News
More News >
Stayble Therapeutics AB (DE:4K4)
FRANKFURT:4K4
Germany Market

Stayble Therapeutics AB (4K4) Income Statement

Compare
1 Followers

Stayble Therapeutics AB Income Statement

Last quarter (Q4 2024), Stayble Therapeutics AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, Stayble Therapeutics AB's net income was kr-3.01M. See Stayble Therapeutics AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00-
Gross Profit
kr 0.00kr 0.00kr 0.00kr 0.00-
Operating Expenses
kr 23.95Mkr 24.95Mkr 12.14Mkr 14.98Mkr 6.87M
Depreciation and Amortization
kr 24.00Mkr 24.95Mkr 12.14Mkr 14.98Mkr 6.87M
EBITDA
kr 309.41Kkr 0.00kr 0.00kr 0.00kr 0.00
Operating Income
kr -23.95Mkr -24.80Mkr -12.14Mkr -14.93Mkr -6.87M
Other Income/Expenses
kr 217.28Kkr 270.51Kkr 49.52Kkr -562.34Kkr -533.35K
Pretax Income
kr -23.74Mkr -24.53Mkr -12.09Mkr -15.49Mkr -7.41M
Net Income
kr -23.74Mkr -24.23Mkr -12.04Mkr -16.05Mkr -7.94M
Per Share Metrics
Basic EPS
kr -0.92kr -1.70kr -0.85kr -1.80kr -0.63
Diluted EPS
kr -0.92kr -1.70kr -0.85kr -1.80kr -0.63
Weighted Average Shares Outstanding
25.76M 14.23M 14.23M 8.92M 12.59M
Weighted Average Shares Outstanding (Diluted)
25.76M 14.23M 14.23M 8.92M 12.59M
Currency in SEK

Stayble Therapeutics AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis